genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. The Pharmacogenomic Services division offers molecular measures of biological processes. The Diagnostics division is involved in commercializing the Genedrive point of need molecular testing platform. It serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is based in Manchester, the United Kingdom.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-161-9890245
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£1.94 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Genedrive (LON:GDR) Frequently Asked Questions
What is Genedrive's stock symbol?
Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."
How were Genedrive's earnings last quarter?
Genedrive PLC (LON:GDR) announced its quarterly earnings data on Tuesday, March, 20th. The company reported ($9.00) earnings per share for the quarter. The firm had revenue of $2.63 million for the quarter. View Genedrive's Earnings History.
What price target have analysts set for GDR?
0 brokerages have issued 12 month price objectives for Genedrive's stock. Their predictions range from GBX 152 to GBX 152. On average, they expect Genedrive's share price to reach GBX 152 in the next year. This suggests a possible upside of 546.8% from the stock's current price. View Analyst Price Targets for Genedrive.
Has Genedrive been receiving favorable news coverage?
News articles about GDR stock have been trending positive on Sunday, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Genedrive earned a media sentiment score of 2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Genedrive's key competitors?
Some companies that are related to Genedrive include Sernova (SVA), GeneNews (GEN), Cambridge Cognition (COG), Deepmatter Group (DMTR), SQI Diagnostics (SQD), LED Medical Diagnostics (LMD), VentriPoint Diagnostics (VPT), Smiles Inclusive (SIL), Dorsavi (DVL), 3D Signatures (DXD), Imaging Dynamics (IDL), Med Biogene (MBI), BioMark Diagnostics (BUX), BioNano Genomics (BNGOU) and Breathtec Biomedical (BTH).
What other stocks do shareholders of Genedrive own?
Who are Genedrive's key executives?
Genedrive's management team includes the folowing people:
- Mr. David Budd, CEO & Director (Age 51)
- Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 44)
How do I buy shares of Genedrive?
Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genedrive's stock price today?
One share of GDR stock can currently be purchased for approximately GBX 23.50.
How big of a company is Genedrive?
Genedrive has a market capitalization of £7.98 million and generates £1.94 million in revenue each year.
What is Genedrive's official website?
How can I contact Genedrive?
Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245.
MarketBeat Community Rating for Genedrive (LON GDR)
MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
